TGF-beta, a 'double agent' in the immune pathology war

An IL-12 partial agonist sustains intratumoral lymphocyte activation and detoxifies systemic IL-12 therapy.

Cell reports·2025

IL-23 tunes inflammatory functions of human mucosal-associated invariant T cells.

iScience·2025

IL-23 past, present, and future: a roadmap to advancing IL-23 science and therapy.

Frontiers in immunology·2024

Association between enthesitis/dactylitis resolution and patient-reported outcomes in guselkumab-treated patients with psoriatic arthritis.

Clinical rheumatology·2024

Local IL-23 is required for proliferation and retention of skin-resident memory TH17 cells.

Science immunology·2022

Induction and Analysis of Anti-CD40-induced Colitis in Mice.

Bio-protocol·2021

Rediscovering eosinophil identity through tissue adaptation.

Nature immunology·2026

ALOX15 orchestrates mitochondrial antiviral immunity and serves as a host target for anti-influenza therapy.

Nature immunology·2026

Implications of RNA virus persistence for post-acute sequelae and chronic inflammatory syndromes.

Nature immunology·2026

Exhausted CD8+ T cell fate is programmed by dynamic CTCF-mediated enhancer activation and invariant CTCF-imposed barriers.

Nature immunology·2026

Mapping self-associating chromatin hubs identifies Id proteins as key determinants of exhausted CD8+ T cell fate.

Nature immunology·2026

Pregnancy-induced tissue-resident memory-like T cells contribute to tumor control in breast cancer.

Nature immunology·2026

Correction: An integrated automated deep learning framework for annotating tumor-infiltrating lymphocytes in lung adenocarcinoma pathology.

Frontiers in bioinformatics·2026

Development and pilot validation of a chemiluminescence immunoassay for monitoring immunologic changes during peanut oral immunotherapy using sIgE/sIgG4 ratio.

Frontiers in allergy·2026

Real-world outcomes of subcutaneous infliximab in a Middle Eastern inflammatory bowel disease cohort: a prospective study of switch and de novo treatment strategies.

Crohn's & colitis 360·2026

A pipeline for cell migration analysis in live-cell imaging data from human iPSC-derived forebrain assembloids.

Frontiers in cell and developmental biology·2026

Tislelizumab-induced myositis antibody-negative myasthenia gravis in patients with urothelial carcinoma: a case report.

Frontiers in immunology·2026

Case Report: Localized neutrophilic dermatosis at a split-skin donor site during PD-1 blockade: a unique immune-related adverse event.

Frontiers in immunology·2026

Related Experiment Videos

TGF-beta, a 'double agent' in the immune pathology war

Related Concept Videos

An IL-12 partial agonist sustains intratumoral lymphocyte activation and detoxifies systemic IL-12 therapy.

IL-23 tunes inflammatory functions of human mucosal-associated invariant T cells.

IL-23 past, present, and future: a roadmap to advancing IL-23 science and therapy.

Association between enthesitis/dactylitis resolution and patient-reported outcomes in guselkumab-treated patients with psoriatic arthritis.

Local IL-23 is required for proliferation and retention of skin-resident memory TH17 cells.

Induction and Analysis of Anti-CD40-induced Colitis in Mice.

Rediscovering eosinophil identity through tissue adaptation.

ALOX15 orchestrates mitochondrial antiviral immunity and serves as a host target for anti-influenza therapy.

Implications of RNA virus persistence for post-acute sequelae and chronic inflammatory syndromes.

Exhausted CD8+ T cell fate is programmed by dynamic CTCF-mediated enhancer activation and invariant CTCF-imposed barriers.

Mapping self-associating chromatin hubs identifies Id proteins as key determinants of exhausted CD8+ T cell fate.

Pregnancy-induced tissue-resident memory-like T cells contribute to tumor control in breast cancer.

Correction: An integrated automated deep learning framework for annotating tumor-infiltrating lymphocytes in lung adenocarcinoma pathology.

Development and pilot validation of a chemiluminescence immunoassay for monitoring immunologic changes during peanut oral immunotherapy using sIgE/sIgG4 ratio.

Real-world outcomes of subcutaneous infliximab in a Middle Eastern inflammatory bowel disease cohort: a prospective study of switch and de novo treatment strategies.

A pipeline for cell migration analysis in live-cell imaging data from human iPSC-derived forebrain assembloids.

Tislelizumab-induced myositis antibody-negative myasthenia gravis in patients with urothelial carcinoma: a case report.

Case Report: Localized neutrophilic dermatosis at a split-skin donor site during PD-1 blockade: a unique immune-related adverse event.

Related Experiment Videos

TGF-beta, a 'double agent' in the immune pathology war

Related Concept Videos

Related Articles